These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8693938)

  • 21. Preventing RhD haemolytic disease of the newborn. Services should be centralised for pregnancies affected by RhD haemolytic disease.
    Craig JS; McClure BG; Tubman TR
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9616034
    [No Abstract]   [Full Text] [Related]  

  • 22. RhD hemolytic disease of the newborn.
    Bowman JM
    N Engl J Med; 1998 Dec; 339(24):1775-7. PubMed ID: 9845715
    [No Abstract]   [Full Text] [Related]  

  • 23. Preventing RhD haemolytic disease of the newborn.
    van Dijk B
    BMJ; 1997 Dec; 315(7121):1480-1. PubMed ID: 9420481
    [No Abstract]   [Full Text] [Related]  

  • 24. First report from India of haemolytic disease of newborn by anti-c and anti-E in Rh (D) positive mothers.
    Thakral B; Agrawal SK; Dhawan HK; Saluja K; Dutta S; Marwaha N
    Hematology; 2007 Oct; 12(5):377-80. PubMed ID: 17852437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of feto-maternal red cell allo-immunizations].
    Bricca P; Guinchard E; Guitton Bliem C
    Transfus Clin Biol; 2011 Apr; 18(2):269-76. PubMed ID: 21397546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adverse effects and patient information].
    Cortey A; Brossard Y
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S112-1S118. PubMed ID: 16495836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preventing RhD haemolytic disease of the newborn. Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis.
    Lee D
    BMJ; 1998 May; 316(7144):1611. PubMed ID: 9596614
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical significance of anti-G.
    Lenkiewicz B; Zupańska B
    Transfus Med; 2002 Jun; 12(3):221. PubMed ID: 12071879
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemolytic disease of the newborn due to anti-c.
    Saenz RB
    J Tenn Med Assoc; 1993 Jan; 86(1):9-11. PubMed ID: 8455385
    [No Abstract]   [Full Text] [Related]  

  • 30. Successful treatment of severe rhesus D-incompatible pregnancy with repeated double-filtration plasmapheresis.
    Kamei K; Yamaguchi K; Sato M; Ogura M; Ito S; Okada T; Wada S; Sago H
    J Clin Apher; 2015 Oct; 30(5):305-7. PubMed ID: 25413689
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgG subclasses of anti-Rh(D) and haemolytic disease of the newborn.
    Eklund J; Jouppila P; Seppälä IJ
    Vox Sang; 1988; 55(1):51-2. PubMed ID: 3138818
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of fetomaternal rhesus-D allo-immunization. Perspectives].
    Cortey A; Brossard Y; Beliard R; Bourel D
    J Gynecol Obstet Biol Reprod (Paris); 2006 Feb; 35(1 Suppl):1S119-1S122. PubMed ID: 16495837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Spontaneous antepartal RhD alloimmunization].
    Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
    Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevention of fetal erythroblastosis with anti-D immunoglobulin].
    Rasteński J; Gryglicka M
    Acta Haematol Pol; 1988; 19(3-4):239-41. PubMed ID: 3150900
    [No Abstract]   [Full Text] [Related]  

  • 35. When is an anti-D antibody not an anti-D antibody?
    Merron BM; Maguire K; Morris K
    Transfus Med; 2015 Apr; 25(2):115-7. PubMed ID: 25925731
    [No Abstract]   [Full Text] [Related]  

  • 36. Maternal ABO-mismatched blood for intrauterine transfusion of severe hemolytic disease of the newborn due to anti-Rh17.
    Denomme GA; Ryan G; Seaward PG; Kelly EN; Fernandes BJ
    Transfusion; 2004 Sep; 44(9):1357-60. PubMed ID: 15318861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe hemolytic disease of the fetus and newborn due to allo-anti-D in a patient with a partial DEL phenotype arising from the variant allele described as RHD*148+1T (RHD*01EL.31).
    Turley E; McGowan EC; Hyland CA; Schoeman EM; Flower RL; Skoll A; Delisle MF; Nelson T; Clarke G; Au N
    Transfusion; 2018 Oct; 58(10):2260-2264. PubMed ID: 30222865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hemolytic disease of the newborn has not vanished from Finland--routine protection of RhD negative mothers during pregnancy is justifiable].
    Sainio S; Kuosmanen M
    Duodecim; 2012; 128(2):151-7. PubMed ID: 22372070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Decreasing Rhesus serum antibody titer in pregnancy with Rhesus constellation].
    Kölbl H; Riss P
    Geburtshilfe Frauenheilkd; 1987 Apr; 47(4):285-6. PubMed ID: 3110000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hospitals should not treat pregnancy with Rh-immunization].
    Lakartidningen; 1988 Oct; 85(40):3303. PubMed ID: 3143870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.